| |
Total
|
Low MYSM1
|
High MYSM1
| | |
|---|
|
Variable
|
N
|
%
|
N
|
%
|
N
|
%
|
χ2
|
P Valuea
|
|---|
|
Pathological Diagnosis
|
|
Adjacent Normal Tissue
|
38
|
30.7
|
6
|
9.5
|
32
|
52.5
|
32.054
|
< 0.001
|
|
Adenocarcinoma
|
53
|
42.7
|
30
|
47.6
|
23
|
37.7
|
|
Lymph Node Metastasis
|
33
|
26.6
|
27
|
42.9
|
6
|
9.8
|
|
Adjacent Normal Tissue
|
38
|
41.8
|
6
|
16.7
|
32
|
58.2
|
15.419
|
< 0.001
|
|
Adenocarcinoma
|
53
|
58.2
|
30
|
83.3
|
23
|
41.8
|
|
Adenocarcinoma
|
53
|
61.6
|
30
|
52.6
|
23
|
79.3
|
5.785
|
0.016
|
|
Lymph Node Metastasis
|
33
|
38.4
|
27
|
47.4
|
6
|
20.7
|
|
Adjacent Normal Tissue
|
38
|
53.5
|
6
|
18.2
|
32
|
84.2
|
30.955
|
< 0.001
|
|
Lymph Node Metastasis
|
33
|
46.5
|
27
|
81.8
|
6
|
15.8
|
|
Location
|
|
Colon
|
45
|
84.9
|
28
|
93.3
|
17
|
73.9
|
3.831
|
0.050
|
|
Rectum
|
8
|
15.1
|
2
|
6.7
|
6
|
26.1
|
|
Age (y)
|
|
< 40
|
8
|
15.1
|
5
|
16.7
|
3
|
13.0
|
1.065
|
0.587
|
|
40–60
|
28
|
52.8
|
14
|
46.7
|
14
|
60.9
|
|
> 60
|
17
|
32.1
|
11
|
36.6
|
6
|
26.1
|
|
Gender
|
|
M
|
38
|
71.7
|
21
|
70.0
|
17
|
73.9
|
0.098
|
0.754
|
|
F
|
15
|
28.3
|
9
|
30.0
|
6
|
26.1
|
|
Grade
|
|
I
|
10
|
18.9
|
8
|
26.7
|
2
|
8.7
|
2.783
|
0.249
|
|
II
|
26
|
49.1
|
13
|
43.3
|
13
|
56.5
|
|
III
|
17
|
32.0
|
9
|
30.0
|
8
|
34.8
|
|
Stage
|
|
≤ IIIB
|
44
|
83.0
|
22
|
73.3
|
22
|
95.7
|
4.600
|
0.032
|
|
≥ IIIC
|
9
|
17.0
|
8
|
26.7
|
1
|
4.3
|
|
Tumor Stage
|
|
≤ T3
|
35
|
66.0
|
16
|
53.3
|
19
|
82.6
|
4.975
|
0.026
|
|
T4
|
18
|
34.0
|
14
|
46.7
|
4
|
17.4
|
|
Nodal Stage
|
|
N0
|
13
|
24.5
|
9
|
30.0
|
4
|
17.4
|
1.759
|
0.415
|
|
N1
|
27
|
51.0
|
13
|
43.3
|
14
|
60.9
|
|
N2
|
13
|
24.5
|
8
|
26.7
|
5
|
21.7
|
- aThe P values were calculated in SPSS 25.0 using a chi-square test
- P values < 0.05 were considered to indicate statistical significance
